# A Prospective, Multi-center Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS Element™)

> **NCT00824434** · PHASE3 · COMPLETED · sponsor: **Boston Scientific Corporation** · enrollment: 100 (actual)

## Conditions studied

- Atherosclerosis
- Coronary Artery Disease

## Interventions

- **DEVICE:** PROMUS Element™

## Key facts

- **NCT ID:** NCT00824434
- **Lead sponsor:** Boston Scientific Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-03
- **Primary completion:** 2009-09
- **Final completion:** 2010-08
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2012-08-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00824434

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00824434, "A Prospective, Multi-center Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS Element™)". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT00824434. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*